Law on Medical Examination & Treatment in force
Replaces the 2009 law; introduces a 5-year CCHN KCB validity, a CME mandate, and establishes the Hội đồng Y khoa Quốc gia (National Medical Council) as the body that will run the future licensing exam.
Regulatory calendar
A chronological view of recent and upcoming Vietnamese regulatory milestones across pharma, cosmetic, food and medical practice. Each milestone shows the governing document, affected product kinds and a link to a Medibase deep-dive article when one exists.
| Effective date | Document ID | Name | Affected kinds |
|---|---|---|---|
| 2024-01-01 | Luật 15/2023/QH15 | Law on Medical Examination & Treatment in force | practice |
| 2024-11-21 | Luật 44/2024/QH15 | Pharmacy Law amendment passed | drug |
| 2025-01-01 | Nghị định 96/2023/NĐ-CP | Three-tier medical facility system in force | practice |
| 2025-07-01 | Luật 44/2024/QH15 | Pharmacy Law amendment effective | drug |
| 2025-07-01 | NĐ 163/2025/NĐ-CP | Decree implementing the amended Pharmacy Law in force | drug |
| 2025-07-01 | TT 31/2025/TT-BYT | Drug-registration procedure circular | drug |
| 2025-07-01 | TT 28/2025/TT-BYT | GMP for drug manufacturing — refreshed | drug |
| 2025-07-01 | TT 11/2025/TT-BYT | Good Pharmacy Practice — consolidated text | drug |
| 2025-10-25 | TT 40/2025/TT-BYT | Public-hospital drug procurement — refreshed | drug, tender |
| 2025-12-31 | Hague Apostille Convention 1961 | Vietnam deposits accession to the Hague Apostille Convention | medical_device, drug, treaty |
| 2026-01-01 | Luật 112/2025/QH15 | Terminology law for the medical-practitioner exam | practice |
| 2026-01-26 | NĐ 46/2026/NĐ-CP | Food-safety decree signed and originally effective | food, supplement |
| 2026-02-04 | NQ 09/2026/NQ-CP | NQ 09/2026 suspends NĐ 46/2026 (initially until 15 April 2026) | food, supplement |
| 2026-02-27 | TT 50/2025/TT-BYT | Clinical-trial application procedure refreshed | drug |
| 2026-04-06 | NQ 15/2026/NQ-CP | NQ 15/2026 extends suspension of NĐ 46/2026 indefinitely | food, supplement |
| 2026-04-29 | NQ 21/2026/NQ-CP | Food-advertising approval delegated to provinces | food, supplement |
| 2026-06-01 | TT 18/2026/TT-BYT | Special-control medicines circular signed | drug |
| 2026-07-01 | NQ 21/2026/NQ-CP | Practice-licensing & advertising authority moves to provinces | practice |
| 2026-07-16 | TT 18/2026/TT-BYT | Special-control medicines — full effect | drug |
Replaces the 2009 law; introduces a 5-year CCHN KCB validity, a CME mandate, and establishes the Hội đồng Y khoa Quốc gia (National Medical Council) as the body that will run the future licensing exam.
National Assembly passes the Pharmacy Law amendment (amends Luật Dược 105/2016); takes effect 1 July 2025.
Cấp ban đầu / cấp cơ bản / cấp chuyên sâu replaces the legacy four-tier scheme; reshapes referral pathways and BHYT entitlement.
Automatic-extension safety net for in-flight renewals, explicit reference-dossier pathway for SRA-approved products, 3-month renewal window (down from 12), dedicated innovative-drug pathway.
Implements Law 44/2024: special-control drug classification, storage / production / distribution rules, FIE notification regime (Art. 91 §12).
Operational circular for Luật Dược Chapter IV — dossier modules, timelines, expert-council process.
Replaces Circular 35/2018/TT-BYT with an updated GMP framework aligned to PIC/S developments.
Consolidated GPP text integrated with the electronic drug-records requirement.
Vietnam deposits the instrument of accession to the 1961 Hague Apostille Convention; replaces consular legalisation for most public documents from foreign signatories — major simplification for FSC / CPP / GMP packs.
Terminology update preparing the legal framework for the National Medical Licensing Examination (NMLE) pilot.
Signed and originally effective for 9 days before being suspended on 2026-02-04 (see next entry). Would have replaced NĐ 15/2018/NĐ-CP — self-declaration → conformity registration, packaging brought in-scope, HACCP / GMP / ISO 22000 mandate by 31 Dec 2026 — but none of those obligations are currently operating. NĐ 15/2018 continues to apply.
Resolution 09/2026/NQ-CP suspends Decree 46 (and Resolution 66.13/2026/NQ-CP on product declaration) following the customs-clearance crisis. NĐ 15/2018 continues to apply. The 75-day window was subsequently extended indefinitely by NQ 15/2026 — see the 6 April 2026 entry.
Replaces Circular 50/2018; tightens timelines and aligns with ICH expectations for first-in-human and reference-product trials.
Resolution 15/2026/NQ-CP extends the suspension of Decree 46/2026 (and Resolution 66.13/2026/NQ-CP) until the revised Food Safety Law and its implementing decrees take effect. NĐ 15/2018 continues to apply; dossiers filed before this resolution are handled per NĐ 15/2018. The revised Food Safety Law is expected at the September 2026 UBTVQH session (Resolution 119/2026/UBTVQH15).
Delegates food-advertising approval authority from the central VFA to provincial UBND; takes operational effect 1 July 2026.
Implementing circular for the special-control medicines regime. Etomidate and Carisoprodol reclassified as psychotropic effective immediately on signature; other provisions wait for 16 July 2026.
CCHN KCB issuance moves from MOH to the provincial People's Committee Chairperson; food-advertising approval operationally devolves to provinces; partial BHYT cover begins for select cross-tier outpatient services.
Procedures, storage rules, prescription / dispensing / disposal controls under TT 18/2026/TT-BYT all become active.